Home
About Us
Overview
Leadership
Board of Directors
Message from BIO
Programs
Overview
Tamibarotene
SY-2101
SY-5609
Expanded Access Policy
Publications
All Publications
Tamibarotene
SY-2101
SY-5609
Patients
Investors & Media
Partners
Careers
Blog
Contact
Investors & Media
Investors & Media
Overview
News
Email Alerts
Press Releases
Events & Presentations
IR Calendar
Presentations
Company Info
Profile
Leadership
Contacts
Analyst Coverage
FAQ
Financial Info
Balance Sheet
Income Statement
Cash Flow
Financial Results
Annual Reports
IRS Tax Form 8937
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Filings
Quarterly Reports
Proxy
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Investor & Media Tools
Email Alerts
Fact Sheet
Tear Sheet
Contacts
RSS News Feed
All SEC Filings
SEC Filings
Overview
All SEC Filings
Annual Filings
Quarterly Reports
Proxy
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEL AM
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-4MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Date
Form
Description
PDF
XBRL
Pages
09/19/22
4
Statement of changes in beneficial ownership of securities
1
09/19/22
4
Statement of changes in beneficial ownership of securities
1
09/19/22
4
Statement of changes in beneficial ownership of securities
1
09/19/22
4
Statement of changes in beneficial ownership of securities
1
09/19/22
4
Statement of changes in beneficial ownership of securities
1
09/19/22
3
Initial statement of beneficial ownership of securities
Documents
EX-24
2
09/19/22
3
Initial statement of beneficial ownership of securities
Documents
EX-24
2
09/19/22
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
8
09/19/22
S-4MEF
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-4
Documents
EX-5.1
EX-23.2
EX-23.3
EX-FILING FEES
10
09/16/22
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
4
10
11
12
13
14
15
16
17
18
19